Litcius/Paper detail

Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy

Zheng Hu, Wanqiong Li, Shaomeng Chen, Danhong Chen, Ran Xu, Danlu Zheng, Xin Yang, Shuzhen Li, Xiuman Zhou, Xiaoshuang Niu, Youmei Xiao, Zhuoying He, Huihao Li, Juan Liu, Xinghua Sui, Yanfeng Gao

2023Science China Life Sciences32 citationsDOI

Topics & Concepts

Cancer immunotherapyCancer researchCD47ImmunotherapyT cellImmune systemImmune checkpointChemistryBiologyImmunologyPhagocytosis and Immune RegulationImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy | Litcius